Advertisement

Spinal Tech

Michel Orsinger, CEO of Synthes, recently received $52 million as a result of Johnson & Johnson's acquisition of the company, if the deal closes sometime over the next two years, according to a Philadelphia Inquirer report.

Advertisement

A new study led by Art Sedrakyan, MD, of Weill Cornell Medical College in New York City, recently found that new metal-on-metal and ceramic-on-ceramic hip implants have no better outcomes than traditional polyethylene implants, according to a Weill Cornell news…

Advertisement